A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel and/or Mouth Rinse Doses to Healthy Adult Subjects
Phase of Trial: Phase II
Latest Information Update: 11 Jan 2017
At a glance
- Drugs C 16G2 (Primary)
- Indications Dental caries; Streptococcal infections
- Focus Adverse reactions
- Sponsors C3 Jian
- 09 Sep 2014 Status changed from active, no longer recruiting to completed.
- 09 Sep 2014 Results published in the Media Release.
- 10 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History